About Iantrek
Iantrek is a company based in White Plains (United States) founded in 2019 by Sean Ianchulev.. Iantrek has raised $67.78 million across 3 funding rounds from investors including Visionary Ventures, Sectoral Asset Management and USVP. The company has 2 employees as of December 31, 2021. Iantrek offers products and services including CycloPen, AlloFlo, and C-Rex. Iantrek operates in a competitive market with competitors including Sight Sciences, Alcon, Keranova, Zhitong Technology and Migos Medical, among others.
- Headquarter White Plains, United States
- Employees 2 as on 31 Dec, 2021
- Founders Sean Ianchulev
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Iantrek, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$67.78 M (USD)
in 3 rounds
-
Latest Funding Round
$42 M (USD), Series C
Aug 20, 2025
-
Investors
Visionary Ventures
& 4 more
-
Employee Count
2
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Iantrek
Iantrek offers a comprehensive portfolio of products and services, including CycloPen, AlloFlo, and C-Rex. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for controlled creation of cyclodialysis in glaucoma surgery.
Enhances outflow in eyes through precision scleral reinforcement.
Device for circumferential, excisional goniotomy procedures.
Unlock access to complete
Unlock access to complete
Funding Insights of Iantrek
Iantrek has successfully raised a total of $67.78M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $42 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $42.0M
-
First Round
First Round
(09 Aug 2022)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Series C - Iantrek | Valuation | USVP | |
| Feb, 2025 | Amount | Series B - Iantrek | Valuation |
investors |
|
| Aug, 2022 | Amount | Series B - Iantrek | Valuation | Visionary Ventures , Sectoral |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Iantrek
Iantrek has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Visionary Ventures, Sectoral Asset Management and USVP. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital fund focused on life sciences investments.
|
Founded Year | Domain | Location | |
|
Sectoral Asset Management is focused on global healthcare investment.
|
Founded Year | Domain | Location | |
|
VC firm that focuses on early stage investments in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Iantrek
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Iantrek
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Iantrek Comparisons
Competitors of Iantrek
Iantrek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sight Sciences, Alcon, Keranova, Zhitong Technology and Migos Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Surgical systems for ophthalmological disease treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a wide range of eye care products
|
|
| domain | founded_year | HQ Location |
Surgical equipment for anterior chamber ophthalmic surgery is developed.
|
|
| domain | founded_year | HQ Location |
Developer of surgical devices for ophthalmic indications
|
|
| domain | founded_year | HQ Location |
Minimally invasive ophthalmology devices for glaucoma are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Iantrek
Frequently Asked Questions about Iantrek
When was Iantrek founded?
Iantrek was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is Iantrek located?
Iantrek is headquartered in White Plains, United States. It is registered at White Plains, New York, United States.
Who is the current CEO of Iantrek?
Sean Ianchulev is the current CEO of Iantrek. They have also founded this company.
Is Iantrek a funded company?
Iantrek is a funded company, having raised a total of $67.78M across 3 funding rounds to date. The company's 1st funding round was a Series B of $23M, raised on Aug 09, 2022.
How many employees does Iantrek have?
As of Dec 31, 2021, the latest employee count at Iantrek is 2.
What does Iantrek do?
Iantrek was founded in 2019 in White Plains, United States, within the medical devices sector focused on ophthalmology. A minimally invasive technology for eye surgery is developed, featuring an implantable biologic stent. This stent is surgically placed to boost aqueous outflow and decrease intraocular pressure, addressing conditions like glaucoma. Operations center on innovation in biologic implants for improved surgical outcomes in eye care.
Who are the top competitors of Iantrek?
Iantrek's top competitors include Alcon, Sight Sciences and Keranova.
What products or services does Iantrek offer?
Iantrek offers CycloPen, AlloFlo, and C-Rex.
Who are Iantrek's investors?
Iantrek has 5 investors. Key investors include Visionary Ventures, Sectoral Asset Management, USVP, JSD I Radius Special Situations, and Civilization Ventures.